Narinder S Shargill
Overview
Explore the profile of Narinder S Shargill including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
619
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Saccomanno J, Sgarbossa T, Pappe E, Kilic L, Biglari S, Shargill N, et al.
ERJ Open Res
. 2024 Jul;
10(4).
PMID: 38978543
https://bit.ly/3HG9iMQ.
2.
Koster T, Shah P, Valipour A, Criner G, Herth F, Sue R, et al.
Respir Med
. 2024 Apr;
227:107639.
PMID: 38642906
Bronchoscopic lung volume reduction treatment with Zephyr one-way valves is an effective guideline-based treatment option for patients with severe emphysema and hyperinflation. However, in some cases the treatment response is...
3.
Koster T, Eberhardt R, Huebner R, Valipour A, Herth F, Klooster K, et al.
Respir Med
. 2022 Sep;
203:106989.
PMID: 36166995
Introduction: Treatment with AeriSeal is an alternate treatment option to achieve lung volume reduction in patients with severe COPD and emphysema who are not eligible for valve treatment. This study...
4.
Criner G, Armstrong B, Shargill N
Respiration
. 2021 Aug;
100(11):1146-1148.
PMID: 34380139
No abstract available.
5.
Eberhardt R, Slebos D, Herth F, Darwiche K, Wagner M, Ficker J, et al.
Respiration
. 2021 Aug;
100(12):1174-1185.
PMID: 34350884
Rationale: The long-term safety and effectiveness of bronchoscopic lung volume reduction with Zephyr endobronchial valves in subjects with severe homogeneous emphysema with little to no collateral ventilation beyond 3 months...
6.
Koster T, Klooster K, McNamara H, Shargill N, Radhakrishnan S, Olivera R, et al.
ERJ Open Res
. 2021 Jul;
7(3).
PMID: 34322555
Introduction: Bronchoscopic lung volume reduction with endobronchial valves is an important treatment option in selected patients with severe emphysema and absence of collateral ventilation in the treatment target lobe. The...
7.
Dransfield M, Garner J, Bhatt S, Slebos D, Klooster K, Sciurba F, et al.
Ann Am Thorac Soc
. 2020 Apr;
17(7):829-838.
PMID: 32223724
Bronchoscopic lung volume reduction with Zephyr Valves improves lung function, exercise tolerance, and quality of life of patients with hyperinflated emphysema and little to no collateral ventilation. analysis of patient-reported...
8.
Criner G, Sue R, Wright S, Dransfield M, Rivas-Perez H, Wiese T, et al.
Am J Respir Crit Care Med
. 2018 May;
198(9):1151-1164.
PMID: 29787288
Rationale: This is the first multicenter randomized controlled trial to evaluate the effectiveness and safety of Zephyr Endobronchial Valve (EBV) in patients with little to no collateral ventilation out to...
9.
Niven R, Simmonds M, Cangelosi M, Tilden D, Cottrell S, Shargill N
J Asthma
. 2017 Jul;
55(4):443-451.
PMID: 28708944
Objective: Bronchial thermoplasty (BT) as an add-on therapy for uncontrolled severe asthma is an alternative to biologic therapies like omalizumab (OM). We conducted an indirect treatment comparison (ITC) to appraise...
10.
Pavord I, Thomson N, Niven R, Corris P, Chung K, Cox G, et al.
Ann Allergy Asthma Immunol
. 2013 Oct;
111(5):402-7.
PMID: 24125149
Background: Patients with severe refractory asthma treated with bronchial thermoplasty (BT), a bronchoscopic procedure that improves asthma control by reducing excess airway smooth muscle, were followed up for 5 years...